US20010020098A1 - Cyanine dyes and synthesis methods thereof - Google Patents

Cyanine dyes and synthesis methods thereof Download PDF

Info

Publication number
US20010020098A1
US20010020098A1 US09/824,316 US82431601A US2001020098A1 US 20010020098 A1 US20010020098 A1 US 20010020098A1 US 82431601 A US82431601 A US 82431601A US 2001020098 A1 US2001020098 A1 US 2001020098A1
Authority
US
United States
Prior art keywords
group
alkyl
dye
substituent
dye compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/824,316
Other versions
US6437141B2 (en
Inventor
Malcolm Randall
Philip Buzby
Thomas Erickson
Joseph Trometer
Joseph Miller
David Ahern
Mark Bobrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PerkinElmer Health Sciences Inc
Original Assignee
NEN Life Science Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEN Life Science Products Inc filed Critical NEN Life Science Products Inc
Priority to US09/824,316 priority Critical patent/US6437141B2/en
Publication of US20010020098A1 publication Critical patent/US20010020098A1/en
Assigned to NEN LIFE SCIENCE PRODUCTS, INC. reassignment NEN LIFE SCIENCE PRODUCTS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOBROW, MARK NORMAN, BUZBY, PHILIP RICHARD, MILLER JR., JOSEPH JOHN, AHERN, DAVID GEORGE, ERICKSON, THOMAS JOSEPH, RANDALL, MALCOLM HARRY, TROMETER, JOSEPH DAVID
Application granted granted Critical
Publication of US6437141B2 publication Critical patent/US6437141B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Definitions

  • This invention relates to the synthesis of cyanine dyes having nucleophilic reactive groups. Further, the present invention includes synthetic methods to produce free reactive thiol, amine or hydroxyl groups from protected substituents, the nucleophilic groups capable of nucleophilic addition to target molecules.
  • Cyanine dyes are now recognized to have widespread application as fluorescent probes which can be conjugated to a variety of biological molecules, thus finding applications in DNA sequencing, flow cytometry and immunoassays. Cyanine dyes are characterized by strong spectral absorption bands with the absorption being tunable over a large spectral range by synthetic design,
  • a practical dye In addition to the spectral characteristics of a cyanine dye, a practical dye is characterized by also being stable during isolation and purification, yet be reactive for covalent bonding with a target molecule under conditions which will not degrade the target molecule.
  • Prior art cyanine dyes having reactive groups capable of covalently bonding a target molecule have all been limited in their utility either by structural stability or the reaction conditions required for coupling of the dye and target molecules.
  • An iodo acetyl moiety attached to a cyanine dye is capable of covalently reacting with a sulfhydryl group of a target molecule.
  • the iodo acetyl group is limited in its utility by the sulfhydryl groups being present in only a small class of proteins.
  • Other reactive moieties have included sulfonic acid, carboxylates, and sulfonates (for example see, Anal. Biochem. 243, 15-27: 1996; Bioconj. Chem. 4, 105-111: 1993; 8, 751-756: 1997; Cytometry 10, 3-10: 1989; 10, 11-19: 1989; U.S. Pat. No. 5,106,990; and J. Chem. Soc. Perkin Transactions 1, 143-7: 1998).
  • Such moieties remain reactive during the course of subsequent chemical transformations and purification or are limited by the reaction conditions for bonding to a target molecule.
  • U.S. Pat. No. 5,627,027 is directed to a method for labeling proteins, cells, nucleic acid and DNA with a cyanine dye, as well as the reaction therebetween.
  • the cyanine dye specified is limited in the position of a reactive group within the dye and its identity is limited to isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, aziridine, sulfonyl halide, acid halide, hydroxy succinimide ester, hydroxy sulfosuccinimide ester, imido ester, glyoxal and aldehyde.
  • the method still further requires forming a covalent bond between the reactive group on the dye, and an amine or hydroxyl group on the material being labeled utilizing an electrophilic mechanism for coupling the dye and material being labeled.
  • U.S. Pat. No. 5,486,616 is directed to particular cyanine dye structures which are water soluble, and capable of reacting with amino, hydroxy or sulfhydryl groups through a reactive moiety.
  • the dye structures including at least one sulfonic acid or sulfonate moiety attached directly to a benzyl portion of the dye utilizing an electrophilic mechanism for coupling the dye and material being labeled.
  • U.S. Pat. No. 5,268,486 discloses water soluble dyes which contain reactive moieties including isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonyl halide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imido ester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal and aldehyde.
  • These dyes are chosen to label target molecules containing amino-, hydroxy- and sulfhydryl groups.
  • indole derivatives which will allow the facile synthesis of stable cyanine dyes with suitably positioned reactive groups for covalent attachment to target molecules.
  • the cyanine dyes should allow covalent bonding to target molecules under conditions which will not degrade the target molecules. They should be stable, easily formed, purified and reactive under conditions of attachment to target molecules.
  • This invention describes the facile synthesis of new, stable indole precursors derived from indoles. These precursors allow the facile synthesis of cyanine dyes with protected thiol, amine or hydroxyl groups. The protected groups can be deprotected to yield free thiol, amine or hydroxyl groups which can be covalently attached to target molecules via a nucleophilic mechanism.
  • a cyanine dye having a more generic utility.
  • the present invention relates to a class of nitrogen containing heterocyclics of the formula:
  • Y 1 is selected from a group consisting of:
  • R 1 , R 2 , R 3 , and R 4 are each independently selected from a group consisting of hydrogen, C 1 -C 6 alkyl group, a C 0 -C 4 alkyl group having a hydrophilic substituent selected from a group consisting of sulfonate, carboxylate, hydroxyl, substituted amines and quaternary amines, optionally, at least one of R 1 -R 4 is the C 0 -C 4 alkyl group having the hydrophilic substituent;
  • R 9 , R 9 ′, R 10 and R 10 ′ are each independently selected from a group consisting of C 1 -C 30 alkyl, and a heteroatom substituted C 1 -C 30 alkyl wherein the heteroatom is O, N or S; and
  • R 11 is selected from a group consisting of
  • R 13 , R′ 13 , R′′ 13 and R ′′′ 13 are each independently C 1 -C 30 alkyl.
  • Q is sulfur, nitrogen or oxygen, X is a halogen and Y is a halogen.
  • the new reaction proceeds by heating a solid mixture of the precursors at elevated temperature for a short period of time.
  • the product is purified using conventional chromatography.
  • the reaction proceeds by heating a suitable suspension of solid nitrogen containing heterocyclic in a suitable reagent solution.
  • the product from the latter method can be purified using conventional methods.
  • indole nucleus occurs widely throughout the animal and plant kingdoms and are components of chemicals found in the human body.
  • the essential amino acid tryptophan which occurs in many peptides and bioactive proteins
  • alkaloids containing the indole nucleus such as Harmaline, Cinchera, Yohimbine, Rauwolfia and Ergot alkaloids have widely differing impacts on biological activities. Indole containing chemicals have been used in industrial applications as dye components and biochemical labeling reagents.
  • the new and facile chemistry described in this application enables the synthesis of many new derivatives of indole containing chemicals by providing a vehicle to add a wide variety of chemical groups to an indole nucleus allowing researchers in the life sciences access to a broader variety of biologically active molecules and labeling reagents for target molecules.
  • long chain hydrocarbons may be added to indole chemicals giving them hydrophobic qualities or alternatively linker molecules may be added that will enable the various biological activities of the indoles to be covalently attached to reporter systems or to be used as the reporter molecule in various biological systems.
  • This chemistry can also be used to synthesize new indole derivatives having interesting and beneficial pharmaceutical properties.
  • New derivatives that act as agonists or antagonists to the various sub classes of serotonin receptors may be formed.
  • New derivatives may also lead to new labeling reagents and alternative methods of attaching labeling reagents, such as cyanine dyes, to target molecules.
  • the new heterocyclic derivatives synthesized by the above methods can be converted to cyanine dyes using conventional chemistry.
  • heterocyclics are operative as precursors for a generic class of cyanine dyes having a protected reactive group for nucleophilic covalent attachment to target molecules.
  • the precursor (1) is condensed to form a fluorescent cyanine dye through a polymethine linkage.
  • R 1 , R 2 , R 3 and R 4 are optionally such that two of these adjacent R groups are fused to form a ring structure.
  • the resulting ring structure also optionally being functionalized to modify solubility and spectral properties.
  • the polymethine linkage being formed by reacting two equivalents of precursor (1) in the presence of a molecule illustratively including trialkyl orthoformate, dialkyl amides, and trialkoxy alkene in the presence of a base.
  • the base is an organic base.
  • the linkage reaction proceeds under ambient air in a refluxing organic solvent, although it proceeds at a slower rate without solvent reflux.
  • the organic base illustratively includes pyridine, phenol and an alkoxide, morpholine, piperidine, t-butylamine, and triethylamine and an amine.
  • the polymethine linkage is a conjugated system having 3, 5, 7 or more linear carbon atoms therein.
  • the polymethine linkage between two molecules of precursor (1) is appreciated to include linear chains, as well as also cyclo-aliphatics, substituted aryl and heterocyclic ring structures coupled to the conjugate system of the polymethine chain.
  • a bisaldehyde is more reactive towards the precursors of the present invention than formates, amides or alkoxyalkenes and reaction does not require the presence of a base. Instead, reaction occurs in the presence of an alcohol (J. Org. Chem. 60, 2391-2395: 1995).
  • a 1-formyl-3-(hydroxymethylene)cyclohex-1-ene derivative thus yields a heptamethine linkage.
  • modification and extension of the conjugate bonding across the chain will affect the absorption characteristics of the dye.
  • additional reactive groups or solubility enhancing moieties are readily coupled to the polymethine linkage.
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are each independently selected from a group consisting of hydrogen, C 1 -C 30 alkyl group, a C 0 -C 4 alkyl group having a hydrophilic substituent selected from a group consisting of sulfonate, carboxylate, hydroxyl, substituted amines and quaternary amines;
  • Y 1 and Y 2 are each independently selected from a group consisting of:
  • R 9 , R′ 9 , R 10 , and R′ 10 are each independently selected from a group consisting of C 1 -C 6 alkyl, and a heteroatom substituted C 1 -C 6 alkyl wherein the heteroatom is O, N or S;
  • R 11 and R 12 are each independently selected from a group consisting of C 1 -C 30 alkyl, phenyl substituted C 1 -C 30 , C 1 -C 30 having a protected substituent selected from a group consisting of:
  • R 13 , R′ 13 , R′′ 13 and R′′′ 13 are each independently C 1 -C 30 alkyl;
  • Q is sulfur, nitrogen or oxygen,
  • X is a halogen and
  • Y is a halogen;
  • L is selected from a group consisting of: methine, a methine group having a substituent C 1 -C 6 alkyl group and a substituted C 1 -C 6 alkyl group having a phenyl, hydroxyl, sulfonyl, a halogen atom, a heteroatom substituted phenyl and a C 1 -C 4 alkoxyl where n is 1, 2, 3 or greater.
  • R 1 -R 8 are optionally such that two of these adjacent R groups are fused to form a ring structure.
  • the resulting ring structure also optionally being functionalized to modify solubility and spectral properties.
  • each precursor molecule (1) contains at least one hydrophilic moiety in order to impart water solubility.
  • the hydrophilic moieties illustratively include C 0 -C 4 alkyl-hydroxy, -substituted amino, -quaternary amino, -sulfonate and -carboxylate. It is appreciated that hydrophobic or nonpolar precursors are useful in organic solvent systems.
  • a dye (2) is reactive towards a target molecule upon formation of a thiol, amine or hydroxyl moiety.
  • the thiol, amine or hydroxyl moiety being characterized by a lone pair of electrons sterically and electronically amenable to addition to a reactant which is reactive towards target molecules.
  • the reaction of a dye (2) with a deprotecting agent converts the substituent into a reactive thiol, amine or hydroxyl substituent.
  • Deprotecting agents are well known to the art. (Theodora W. Greene and Peter G. M.
  • an amine or hydroxyl substituent in fact optionally need not be protected, but instead are stable under synthesis conditions and are isolated as such.
  • an amine or hydroxyl substituent operates as a reactive nucleophilic substituent without the occurrence of an intermediate deprotecting reaction.
  • the dyes of the present invention are also amenable to, isolation in deprotected form of free thiols.
  • a free thiol containing dye of the present invention results upon reacting a dye (2) with a deprotecting agent and isolating the free thiol therefrom.
  • the resulting free thiol depending on its specific identity, has a shelf life of more than one month.
  • free thiol cyanine dyes of the present invention are best maintained under conditions suitable to prevent the formation of disulfide linkages. These conditions illustratively include refrigeration, darkness and storage under an inert atmosphere.
  • nitrogen containing heterocyclics identical to (1) except that R 11 is selected from the group consisting of R 14 SH, R 14 NH 2 and R 14 OH are formed directly wherein R 14 is a C 3 -C 30 alkyl and C 3 -C 30 alkyl having a phenyl, hydroxyl, sulfonyl, or halogen atom or a heteroatom substituted phenyl.
  • the reaction chemistry to produce a free thiol dye precursor analog to (1) proceeds in a similar fashion to the formation of protected heterocyclics (1).
  • a cationic nitrogen-containing heterocyclic and a halogenated thiol are able to react via a metatheses reaction to create a free thiol dye precursor.
  • the amine or hydroxyl moiety are produced by analogous type reactions.
  • a free thiol precursor thereafter is reacted in a manner similar to precursor (1) to form a polymethine linkage therebetween.
  • the resulting cyanine dye compound is identical to that of (2) except that R 11 and R 12 are each independently R 14 SH, R 14 NH 2 or R 14 OH when R 14 is a C 3 -C 30 alkyl or C 3 -C 30 alkyl having a phenyl, hydroxyl, sulfonyl, or halogen atom or a heteroatom substituted phenyl.
  • a commercial package of the present invention includes a compound of Formula (1) with instructions and optionally reagents for converting the precursor (1) to a dye compound (2) and further instructions for the use of the dye compound (2) as a dye or hapten. It is appreciated that a free thiol, amine or hydroxyl analog of a compound (1) is also operative herein.
  • a commercial package includes a compound (2) as an active ingredient together with instructions for the use thereof as a dye or hapten in labeling a target molecule. It is also appreciated that a free thiol, amine or hydroxyl analog of a compound (2) is also operative herein.
  • a target molecule which is coupled with a dye of the present invention illustratively includes organic molecules, polymers, silaceous materials, natural and synthetic: lipid vesicles, amino acids, peptide nucleic acids, peptides, nucleic acids, nucleotides, nucleosides, DNA, RNA, proteins, carbohydrates, oligosaccharides, polysaccharides, antibodies, cellular receptors, antigens, haptens, lectins, avidins, streptavidins, lymphokines, hormones, metabolites, toxins, virions, bacteria, fungal components, esinophils, eukaryotic cells, and derivatives thereof.
  • a dye (2) of the present invention in which neither R 11 or R 12 is C 1 -C 30 having a heteroatom containing substituent finds utility as a physi-sorbed, fluorescent dye.
  • a dye of the present invention lacking a heteroatom within R 11 or R 12 is coupled to a target molecule through a hydrophilic moiety of R 1 -R 8 or a pendant reactive moiety extending from the polymethine linkage.
  • Example 1 The procedure of Example 1 is repeated except 2,3,3-trimethyl-5-hydroxyl-6-benz-indolium, potassium salt (6) is substituted for (3).
  • Example 1 The procedure of Example 1 is repeated except 3-methyl-4-carboxyl benzoxizolium, sodium salt (8) is substituted for (3) and 4-bromo-1-S-benzoylbutane (9) is substituted for (4). A solid product 1-[4-S-benzoylbutyl]-3-methyl -4-carboxyl benzoxizolium, inner salt (10) is isolated.
  • Example 1 The procedure of Example 1 is repeated except 3-methyl-5-sulfo-benzoimidazolium (11) and 3-bromo-1-S-t-butyl propane (12) is substituted for (4). A solid product 1-[3-S-t-butylpropyl]-3-methyl-5-sulfo-benzoimidazolium, inner salt (13) is isolated.
  • a solution of (5) (2.68 mmol) and 1-ethyl-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (14) (2.68 mmol) is heated to reflux in pyridine (70 mL) and triethyl orthoformate (24.0 mmol) is added via syringe over 1 hour in four equal portions. The suspension is then heated to reflux for an additional 3 hours and cooled to room temperature. The solvents are removed under reduced pressure and the solid is azeotroped two times with methanol.
  • the solid is purified by Reversed Phase Chromatography and the isolated products are passed over an AG50W-X4, 200-400 mesh K+ form, column to give 1-[3-S-acetylthiopropyl]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (15), 1-[3-S-Acetylthiopropyl]-2-[3-[1-[3-S-acetylthiopropyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (16), and 1-ethyl-2-[3-[1-e
  • Example 5 The procedure of Example 5 is repeated with (7), (10) and (13) substituted for (5) and the 1-ethyl-analogs of (7), (10) and (13) substituted for (14).
  • the resulting solid compounds which are isolated in purified form are summarized in Table 1.
  • a solution of (5) (1.60 mmol), (14) (1.60 mmol) and potassium acetate (3.56 mmol) in -methanol (50 mL) is heated to reflux and 1,3,3-trimethoxypropene (21.0 mmol) is added via syringe over 1 hour in four equal portions. The suspension is then heated to reflux for an additional 3 hours and cooled to room temperature.
  • a solution of (32) (0.36 mmol) and 2,3,3-trimethylindoleninium-5-sulfonate, potassium salt (3) (0.46 mmol) are placed in a flask and heated to 148° C. with stirring for 15 minutes under an atmosphere of nitrogen. The reaction mixture is cooled to room temperature and the residue is crystallized from methanol to give 1-[3-isothiouronylpropyl]-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (33) as a powder.
  • a solution of (33) (0.022 mmol) and 1-ethyl-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (14) (0.022 mmol) are dissolved in N,N-dimethylformamide containing 50 uL of triethylamine and the mixture is heated to 60° C. as triethylorthoformate (4 ⁇ 10 uL, 4 ⁇ 0.06 mmol) is added in four portions over 3 hours. The solution is heated at 60° C.
  • the reaction mixture is purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium]-2,5-pyrrolidindione]propanamido]-1-propynyl]-2′-deoxycytidine triphosphate (37).
  • Example 15 The procedure of Example 15 is repeated with (28) substituted for (15).
  • the reaction mixture is purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[3-[1-ethyl-3-methyl-5-sulfo-benz-imidazol-2-ylidene]-1-propenyl]-3,3 dimethyl-5-hydroxyl-6-benz-indolium]-2,5-pyrrolidindione]propanamido]- 1-propynyl]2′-deoxycytidine triphosphate (38).
  • Example 15 The procedure of Example 15 is repeated with (29) substituted for (15).
  • the reaction mixture is purified to give 5-[3-[3-[3-1-[3-thiopropyl]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]- 1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium]-2,5-pyrrolidindione]propanamido]-1-propynyl]-2′-deoxycytidine triphosphate (39).
  • reaction mixture is purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[3 -[1-ethyl- 1 ,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-3H-indolium]-2,5-pyrrolidindione] propanamido]-1-propynyl]-2′-deoxycytidine triphosphate (45).
  • Example 21 The procedure of Example 21 is repeated with (44) substituted for (42).
  • the reaction mixture is purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3 -dimethyl-3H-indolium]-2,5-pyrrolidindione]propanamido] -1-propynyl]-2′-deoxycytidine triphosphate (46).
  • the reaction mixture is purified to give 5-[3-[1-[3-thiopropyl]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium]acetamido-1-propynyl]-2′-deoxycytidine triphosphate (48).
  • Example 23 The procedure of Example 23 is repeated with (29) substituted for (15).
  • the reaction mixture is purified to give 5-[3-[1-[thiopropyl]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium]acetamido-1-propynyl]-2′-deoxycytidine triphosphate (49).
  • a solution of (51) (0.291 mmol) and (14) (0.281 mmol) is heated to reflux in pyridine (30 mL) and triethyl orthoformate (2.4 mmol) is added via syringe over 1 hour in four equal portions. The suspension is then heated to reflux for an additional 4 hours and cooled to room temperature. The solvents are removed under reduced pressure and the solid is azeotroped two times with methanol.
  • the purple solid is purified by Reversed Phase Chromatography and the isolated products are passed over an AG50W-X4, 200-400 mesh K+ form, column to give 1-[N-[3-(tert-butyloxycarbonylamino)-propyl]hexanamide]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]- 1 -propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (52), 1-[N-[3-(tert-butyloxycarbonyl-amino) propyl]hexanamide]-2-[3-[1-[N-[3-(tert-butyloxy-carbonylamino)-propyl]hexanamide]1,3 -dihydro-3 ,3-dimethyl-5-sulfo-2H-indol-2-
  • Streptavidin (15 mg) is dissolved in 1 mL 0.1M sodium phosphate buffer, pH 7.0.
  • Sulfosuccinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate (9 mg) in 0.2 mL dimethylsulfoxide is added to the streptavidin solution at room temperature, mixed for 1 hour and purified by gel filtration chromatography to give maleimide derivatized streptavidin.
  • Streptavidin (15 mg) is dissolved in 1 mL 0.1M sodium phosphate buffer, pH 7.0.
  • Sulfosuccinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate (9 mg) in 0.2 mL dimethylsulfoxide is added to the streptavidin solution at room temperature, mixed for 1 hour and purified by gel filtration chromatography to give maleimide derivatized streptavidin.
  • Fmoc-Neurotensin on Resin 100 mg (substitution 0.6 mmol/g) is swelled in dimethy fornamide (DMF) for 30 minutes where Fmoc has the structure:
  • Fmoc is removed by reaction with 25% Piperidine/DMF (about 20 ml ⁇ 3 min, wash with DMF, and 20 ml ⁇ 20 min). Resin is washed with DMF 7 ⁇ 20 ml (1 min each washing step). 25 mg of (N-[gamma-malemidobutryloxy] succinimide ester (Sulfo-GMBS) in DMF (15 ml) is added and mixed with resin 24 hours. After reaction the resin is washed 7 ⁇ 20 ml of DMF. Cyanine (15) (10 mg) solution in DMF/methanol (15 ml) is added along with 5 ml 1 M solution of hydroxylamine in water. Reaction is performed overnight.
  • Fmoc-Galinin on Resin is swelled as in Example 31. Orthogonal protection on Lys 25 ((4,4-dimethyl-2,6 dioxocyclohex-1-ylidene)ethyl-Dde) is removed by reaction with 2% hydrazine hydrate (2 ⁇ 20 ml, 2 min). Resin is washed 6 times with DMF (20 ml). 25 mg of Sulfo-GMBS in DMF (15 ml) is added and mixed with resin for 24 hours. After reaction the resin was washed 7 ⁇ 20 ml of DMF, (15) (10 mg) solution in DMF/MeOH (15 ml) is added along with 5 ml 1 M solution of hydroxylamine in water. Reaction is performed overnight. Labeled galanin is purified and isolated as per Example 32.
  • Bradykinin (3 mg) dissolved in 1 ml of 50 mM sodium dihydrogen phosphate pH 7.5, and added sulfoGMBS (3.4 mg), mixed for 2 hours in room temperature.
  • sulfoGMBS 3.4 mg
  • To the reaction mixture is added 1 ml of solution (5.8 mg) of (29) in sodium dihydrogen phosphate pH 7.5 and 0.5 ml 1M hydroxylamine (pH 7), and mixed overnight. Labeled peptide is lyophilized.
  • Example 33 The procedure of Example 33 is repeated with the substitution of liposomes as per Example 1 of U.S. Pat. No. 4,089,801 for bradykinin.
  • the liposome including lecithin and amyloglucoside therein.
  • a labeled liposome is purified therefrom.
  • the dye (58) is prepared as per Examples 1 and 11 using the amine analog to the dye precursor (5).
  • the dye (58) is combined with (36) as per Example 28 to yield the amine analog to (46).

Abstract

A cyanine dye having the formula
Figure US20010020098A1-20010906-C00001
wherein R1-R8 are each independently selected from a group consisting of hydrogen, C1-C6 alkyl group, and C0-C4 alkyl group having a hydrophilic substituent thereon. R11 and R12 are chosen to include a free or protected thiol, amine or hydroxyl substituent capable of reacting with a target molecule through a nucleophilic displacement mechanism. The dye is useful in labeling a variety of target molecules. Processes are described for synthesizing suitable heterocyclic and indole derivatives as precursors for the aforementioned cyanine dyes.

Description

    RELATED APPLICATION
  • This patent application is a divisional application of U.S. Ser. No. 09/294,678 filed Apr. 19, 1999, and is hereby incorporated by reference. [0001]
    • FIELD OF THE INVENTION
  • This invention relates to the synthesis of cyanine dyes having nucleophilic reactive groups. Further, the present invention includes synthetic methods to produce free reactive thiol, amine or hydroxyl groups from protected substituents, the nucleophilic groups capable of nucleophilic addition to target molecules. [0002]
    • BACKGROUND OF THE INVENTION
  • Cyanine dyes are now recognized to have widespread application as fluorescent probes which can be conjugated to a variety of biological molecules, thus finding applications in DNA sequencing, flow cytometry and immunoassays. Cyanine dyes are characterized by strong spectral absorption bands with the absorption being tunable over a large spectral range by synthetic design, [0003]
  • In addition to the spectral characteristics of a cyanine dye, a practical dye is characterized by also being stable during isolation and purification, yet be reactive for covalent bonding with a target molecule under conditions which will not degrade the target molecule. Prior art cyanine dyes having reactive groups capable of covalently bonding a target molecule have all been limited in their utility either by structural stability or the reaction conditions required for coupling of the dye and target molecules. [0004]
  • An iodo acetyl moiety attached to a cyanine dye is capable of covalently reacting with a sulfhydryl group of a target molecule. The iodo acetyl group is limited in its utility by the sulfhydryl groups being present in only a small class of proteins. Other reactive moieties have included sulfonic acid, carboxylates, and sulfonates (for example see, Anal. Biochem. 243, 15-27: 1996; Bioconj. Chem. 4, 105-111: 1993; 8, 751-756: 1997; Cytometry 10, 3-10: 1989; 10, 11-19: 1989; U.S. Pat. No. 5,106,990; and J. Chem. Soc. Perkin Transactions 1, 143-7: 1998). Such moieties remain reactive during the course of subsequent chemical transformations and purification or are limited by the reaction conditions for bonding to a target molecule. [0005]
  • U.S. Pat. No. 5,627,027 is directed to a method for labeling proteins, cells, nucleic acid and DNA with a cyanine dye, as well as the reaction therebetween. The cyanine dye specified is limited in the position of a reactive group within the dye and its identity is limited to isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, aziridine, sulfonyl halide, acid halide, hydroxy succinimide ester, hydroxy sulfosuccinimide ester, imido ester, glyoxal and aldehyde. The method still further requires forming a covalent bond between the reactive group on the dye, and an amine or hydroxyl group on the material being labeled utilizing an electrophilic mechanism for coupling the dye and material being labeled. [0006]
  • U.S. Pat. No. 5,486,616 is directed to particular cyanine dye structures which are water soluble, and capable of reacting with amino, hydroxy or sulfhydryl groups through a reactive moiety. The dye structures including at least one sulfonic acid or sulfonate moiety attached directly to a benzyl portion of the dye utilizing an electrophilic mechanism for coupling the dye and material being labeled. [0007]
  • U.S. Pat. No. 5,268,486 discloses water soluble dyes which contain reactive moieties including isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonyl halide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imido ester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal and aldehyde. These dyes are chosen to label target molecules containing amino-, hydroxy- and sulfhydryl groups. [0008]
  • In view of the prior art, it is apparent that there exists a need for a wider range of indole derivatives which will allow the facile synthesis of stable cyanine dyes with suitably positioned reactive groups for covalent attachment to target molecules. The cyanine dyes should allow covalent bonding to target molecules under conditions which will not degrade the target molecules. They should be stable, easily formed, purified and reactive under conditions of attachment to target molecules. This invention describes the facile synthesis of new, stable indole precursors derived from indoles. These precursors allow the facile synthesis of cyanine dyes with protected thiol, amine or hydroxyl groups. The protected groups can be deprotected to yield free thiol, amine or hydroxyl groups which can be covalently attached to target molecules via a nucleophilic mechanism. [0009]
  • In view of the prior art, it is apparent that there exists a need for a cyanine dye having a more generic utility. A need exists for a cyanine dye which is water soluble and contains at least one reactive moiety capable of labeling a range of substances in addition to compounds containing amino, hydroxy and sulfhydryls through covalent bonding with target molecules under conditions which will not degrade a target molecule. [0010]
  • Prior coupling reactions have been carried out by an electrophilic mechanism. Thus, there further exists a need for a generic class of cyanine dyes which are capable of coupling to a target molecule by a nucleophilic mechanism. [0011]
    • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention relates to a class of nitrogen containing heterocyclics of the formula: [0012]
    Figure US20010020098A1-20010906-C00002
  • wherein Y[0013] 1 is selected from a group consisting of:
    Figure US20010020098A1-20010906-C00003
  • wherein R[0014] 1, R2, R3, and R4 are each independently selected from a group consisting of hydrogen, C1-C6 alkyl group, a C0-C4 alkyl group having a hydrophilic substituent selected from a group consisting of sulfonate, carboxylate, hydroxyl, substituted amines and quaternary amines, optionally, at least one of R1-R4 is the C0-C4 alkyl group having the hydrophilic substituent;
  • wherein R[0015] 9, R9′, R10 and R10′ are each independently selected from a group consisting of C1-C30 alkyl, and a heteroatom substituted C1-C30 alkyl wherein the heteroatom is O, N or S; and
  • wherein R[0016] 11 is selected from a group consisting of
    Figure US20010020098A1-20010906-C00004
  • wherein R[0017] 13, R′13, R″13 and R′″ 13 are each independently C1-C30 alkyl. Q is sulfur, nitrogen or oxygen, X is a halogen and Y is a halogen.
  • Prior to the present invention it has been difficult to synthesize N substituted heterocyclics and indoles in particular with hydrocarbon moieties containing protected nucleophilic groups. The present invention describes a facile reaction between bifunctional hydrocarbons containing the moiety XR[0018] 13Q where X is chlorine, bromine or iodine, R13 is C1-C30 alkyl and Q is sulfur, nitrogen or oxygen; and nitrogen containing heterocyclics which leads to heterocyclics having protected nucleophilic groups in the primary position on the new N-substituent or a moiety which can be converted to a protected nucleophilic group such as a thiol, amine or alcohol. The new reaction proceeds by heating a solid mixture of the precursors at elevated temperature for a short period of time. The product is purified using conventional chromatography. Alternatively the reaction proceeds by heating a suitable suspension of solid nitrogen containing heterocyclic in a suitable reagent solution. The product from the latter method can be purified using conventional methods.
  • Chemicals containing the indole nucleus occur widely throughout the animal and plant kingdoms and are components of chemicals found in the human body. For example, the essential amino acid tryptophan (which occurs in many peptides and bioactive proteins) contains an indole nucleus and is the biochemical precursor to serotonin which is the important neurotransmitter involved in learning, memory, depression and feeding behavior. Many naturally occurring alkaloids containing the indole nucleus such as Harmaline, Cinchera, Yohimbine, Rauwolfia and Ergot alkaloids have widely differing impacts on biological activities. Indole containing chemicals have been used in industrial applications as dye components and biochemical labeling reagents. [0019]
  • The new and facile chemistry described in this application enables the synthesis of many new derivatives of indole containing chemicals by providing a vehicle to add a wide variety of chemical groups to an indole nucleus allowing researchers in the life sciences access to a broader variety of biologically active molecules and labeling reagents for target molecules. For example, long chain hydrocarbons may be added to indole chemicals giving them hydrophobic qualities or alternatively linker molecules may be added that will enable the various biological activities of the indoles to be covalently attached to reporter systems or to be used as the reporter molecule in various biological systems. This chemistry can also be used to synthesize new indole derivatives having interesting and beneficial pharmaceutical properties. In research, new derivatives that act as agonists or antagonists to the various sub classes of serotonin receptors may be formed. New derivatives may also lead to new labeling reagents and alternative methods of attaching labeling reagents, such as cyanine dyes, to target molecules. [0020]
  • The new heterocyclic derivatives synthesized by the above methods can be converted to cyanine dyes using conventional chemistry. [0021]
  • These heterocyclics are operative as precursors for a generic class of cyanine dyes having a protected reactive group for nucleophilic covalent attachment to target molecules. The precursor (1) is condensed to form a fluorescent cyanine dye through a polymethine linkage. [0022]
  • R[0023] 1, R2, R3 and R4 are optionally such that two of these adjacent R groups are fused to form a ring structure. The resulting ring structure also optionally being functionalized to modify solubility and spectral properties.
  • The polymethine linkage being formed by reacting two equivalents of precursor (1) in the presence of a molecule illustratively including trialkyl orthoformate, dialkyl amides, and trialkoxy alkene in the presence of a base. Preferably, the base is an organic base. The linkage reaction proceeds under ambient air in a refluxing organic solvent, although it proceeds at a slower rate without solvent reflux. The organic base illustratively includes pyridine, phenol and an alkoxide, morpholine, piperidine, t-butylamine, and triethylamine and an amine. The polymethine linkage is a conjugated system having 3, 5, 7 or more linear carbon atoms therein. [0024]
  • The polymethine linkage between two molecules of precursor (1) is appreciated to include linear chains, as well as also cyclo-aliphatics, substituted aryl and heterocyclic ring structures coupled to the conjugate system of the polymethine chain. For instance, a bisaldehyde is more reactive towards the precursors of the present invention than formates, amides or alkoxyalkenes and reaction does not require the presence of a base. Instead, reaction occurs in the presence of an alcohol (J. Org. Chem. 60, 2391-2395: 1995). A 1-formyl-3-(hydroxymethylene)cyclohex-1-ene derivative thus yields a heptamethine linkage. Thus, it is appreciated that modification and extension of the conjugate bonding across the chain will affect the absorption characteristics of the dye. Further, it is appreciated that additional reactive groups or solubility enhancing moieties are readily coupled to the polymethine linkage. [0025]
  • The resulting cyanine dye has the formula: [0026]
    Figure US20010020098A1-20010906-C00005
  • wherein R[0027] 1, R2, R3, R4, R5, R6, R7, and R8 are each independently selected from a group consisting of hydrogen, C1-C30 alkyl group, a C0-C4 alkyl group having a hydrophilic substituent selected from a group consisting of sulfonate, carboxylate, hydroxyl, substituted amines and quaternary amines;
  • wherein Y[0028] 1 and Y2 are each independently selected from a group consisting of:
  • wherein R[0029] 9, R′9, R10, and R′10 are each independently selected from a group consisting of C1-C6 alkyl, and a heteroatom substituted C1-C6 alkyl wherein the heteroatom is O, N or S;
    Figure US20010020098A1-20010906-C00006
  • wherein R[0030] 11 and R12 are each independently selected from a group consisting of C1-C30 alkyl, phenyl substituted C1-C30, C1-C30 having a protected substituent selected from a group consisting of:
    Figure US20010020098A1-20010906-C00007
  • wherein R[0031] 13, R′13, R″13 and R′″13 are each independently C1-C30 alkyl; Q is sulfur, nitrogen or oxygen, X is a halogen and Y is a halogen;
  • L is selected from a group consisting of: methine, a methine group having a substituent C[0032] 1-C6 alkyl group and a substituted C1-C6 alkyl group having a phenyl, hydroxyl, sulfonyl, a halogen atom, a heteroatom substituted phenyl and a C1-C4 alkoxyl where n is 1, 2, 3 or greater.
  • R[0033] 1-R8 are optionally such that two of these adjacent R groups are fused to form a ring structure. The resulting ring structure also optionally being functionalized to modify solubility and spectral properties.
  • In order to increase the water solubility of the resulting dye (2), the R[0034] 1, R2, R3, R4, R5, R6, R7, R8, R9, R9′, R10, R10′, R11 and R12 groups are each optionally selected from well known polar and charged moieties. Preferably, each precursor molecule (1) contains at least one hydrophilic moiety in order to impart water solubility. The hydrophilic moieties illustratively include C0-C4 alkyl-hydroxy, -substituted amino, -quaternary amino, -sulfonate and -carboxylate. It is appreciated that hydrophobic or nonpolar precursors are useful in organic solvent systems.
  • A dye (2) is reactive towards a target molecule upon formation of a thiol, amine or hydroxyl moiety. The thiol, amine or hydroxyl moiety being characterized by a lone pair of electrons sterically and electronically amenable to addition to a reactant which is reactive towards target molecules. The reaction of a dye (2) with a deprotecting agent converts the substituent into a reactive thiol, amine or hydroxyl substituent. Deprotecting agents are well known to the art. (Theodora W. Greene and Peter G. M. Wuts, Protective Groups in Organic Synthesis, 2nd edition (1991) 277-308.) It is appreciated that an amine or hydroxyl substituent in fact optionally need not be protected, but instead are stable under synthesis conditions and are isolated as such. Thus, an amine or hydroxyl substituent operates as a reactive nucleophilic substituent without the occurrence of an intermediate deprotecting reaction. [0035]
  • It is appreciated that the dyes of the present invention are also amenable to, isolation in deprotected form of free thiols. A free thiol containing dye of the present invention results upon reacting a dye (2) with a deprotecting agent and isolating the free thiol therefrom. The resulting free thiol, depending on its specific identity, has a shelf life of more than one month. As with other reactive thiols, free thiol cyanine dyes of the present invention are best maintained under conditions suitable to prevent the formation of disulfide linkages. These conditions illustratively include refrigeration, darkness and storage under an inert atmosphere. Alternatively, nitrogen containing heterocyclics identical to (1) except that R [0036] 11 is selected from the group consisting of R14SH, R14NH2 and R14OH are formed directly wherein R14 is a C3-C30 alkyl and C3-C30 alkyl having a phenyl, hydroxyl, sulfonyl, or halogen atom or a heteroatom substituted phenyl. The reaction chemistry to produce a free thiol dye precursor analog to (1) proceeds in a similar fashion to the formation of protected heterocyclics (1). For example, a cationic nitrogen-containing heterocyclic and a halogenated thiol are able to react via a metatheses reaction to create a free thiol dye precursor. The amine or hydroxyl moiety are produced by analogous type reactions. A free thiol precursor thereafter is reacted in a manner similar to precursor (1) to form a polymethine linkage therebetween. The resulting cyanine dye compound is identical to that of (2) except that R11 and R12 are each independently R14SH, R14NH2 or R14OH when R14 is a C3-C30 alkyl or C3-C30 alkyl having a phenyl, hydroxyl, sulfonyl, or halogen atom or a heteroatom substituted phenyl.
  • A commercial package of the present invention includes a compound of Formula (1) with instructions and optionally reagents for converting the precursor (1) to a dye compound (2) and further instructions for the use of the dye compound (2) as a dye or hapten. It is appreciated that a free thiol, amine or hydroxyl analog of a compound (1) is also operative herein. Alternatively, a commercial package includes a compound (2) as an active ingredient together with instructions for the use thereof as a dye or hapten in labeling a target molecule. It is also appreciated that a free thiol, amine or hydroxyl analog of a compound (2) is also operative herein. [0037]
  • The addition of a reactive form of a dye (2) to a target molecule proceeds under conventional nucleophilic reaction conditions. The solvent for the nucleophilic reaction being dictated by the identity of the target molecule. Since many target molecules of interest are of a biological nature, water is often the nucleophilic reaction solvent. [0038]
  • A target molecule which is coupled with a dye of the present invention illustratively includes organic molecules, polymers, silaceous materials, natural and synthetic: lipid vesicles, amino acids, peptide nucleic acids, peptides, nucleic acids, nucleotides, nucleosides, DNA, RNA, proteins, carbohydrates, oligosaccharides, polysaccharides, antibodies, cellular receptors, antigens, haptens, lectins, avidins, streptavidins, lymphokines, hormones, metabolites, toxins, virions, bacteria, fungal components, esinophils, eukaryotic cells, and derivatives thereof. [0039]
  • A dye (2) of the present invention in which neither R[0040] 11 or R12 is C1-C30 having a heteroatom containing substituent finds utility as a physi-sorbed, fluorescent dye. Alternatively, a dye of the present invention lacking a heteroatom within R11 or R12 is coupled to a target molecule through a hydrophilic moiety of R1-R8 or a pendant reactive moiety extending from the polymethine linkage.
  • In order to more fully demonstrate the advantages arising from the present invention, the following examples are set forth. It is to be understood that the following is by way of example only and not intended as a limitation on the scope of the invention. [0041]
    • Example 1 Dye precursor 1-[3-S-Acetylthiopropyl]-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (5)
  • To a 250 mL round bottom flask with magnetic stir bar is added 2,3,3-trimethyl-5-sulfo-3H-indolium, potassium salt (3) (7.21 mmol) and 3-bromo-1-thioacetylpropane (4) (25.88 mmol). The mixture is stirred and heated at 165° C. for 20 min. The residue is cooled to 20° C. and washed with diethyl ether. The solid is purified by Reversed Phase Chromatography to give 1-[3-S-Acetylthio-propyl]-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (5) as a solid. [0042]
    • Example 2 Dye precursor 1-[3-S-Acetylthiopropyl]-2,3,3-trimethyl-5-hydroxyl-6-benzo-3H-indolium, inner salt (7)
  • The procedure of Example 1 is repeated except 2,3,3-trimethyl-5-hydroxyl-6-benz-indolium, potassium salt (6) is substituted for (3). A solid product 1-[3-S-Acetylthiopropyl]-2,3,3-trimethyl-5-hydroxyl-6-benzo-3H-indolium, inner salt (7) is isolated. [0043]
    • Example 3 Dye precursor 1-[4-S-benzoylbutyl]-3-methyl-4-carboxyl benzoxizolium, inner salt (10)
  • The procedure of Example 1 is repeated except 3-methyl-4-carboxyl benzoxizolium, sodium salt (8) is substituted for (3) and 4-bromo-1-S-benzoylbutane (9) is substituted for (4). A solid product 1-[4-S-benzoylbutyl]-3-methyl -4-carboxyl benzoxizolium, inner salt (10) is isolated. [0044]
    • Example 4 Dye precursor 1-[3-S-t-butylpropyl]-3-methyl-5-sulfo-benzoimidazolium, inner salt (13)
  • The procedure of Example 1 is repeated except 3-methyl-5-sulfo-benzoimidazolium (11) and 3-bromo-1-S-t-butyl propane (12) is substituted for (4). A solid product 1-[3-S-t-butylpropyl]-3-methyl-5-sulfo-benzoimidazolium, inner salt (13) is isolated. [0045]
    • Example 5 Cyanine-3 dyes derived from (5)
  • A solution of (5) (2.68 mmol) and 1-ethyl-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (14) (2.68 mmol) is heated to reflux in pyridine (70 mL) and triethyl orthoformate (24.0 mmol) is added via syringe over 1 hour in four equal portions. The suspension is then heated to reflux for an additional 3 hours and cooled to room temperature. The solvents are removed under reduced pressure and the solid is azeotroped two times with methanol. The solid is purified by Reversed Phase Chromatography and the isolated products are passed over an AG50W-X4, 200-400 mesh K+ form, column to give 1-[3-S-acetylthiopropyl]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (15), 1-[3-S-Acetylthiopropyl]-2-[3-[1-[3-S-acetylthiopropyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (16), and 1-ethyl-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (167) as solids. [0046]
    • Examples 6-10 Cyanine-3 dyes derived from (7), (10) and (13)
  • The procedure of Example 5 is repeated with (7), (10) and (13) substituted for (5) and the 1-ethyl-analogs of (7), (10) and (13) substituted for (14). The resulting solid compounds which are isolated in purified form are summarized in Table 1. [0047]
    • Example 11 1-Cyanine-5 dyes derived from (5)
  • A solution of (5) (1.60 mmol), (14) (1.60 mmol) and potassium acetate (3.56 mmol) in -methanol (50 mL) is heated to reflux and 1,3,3-trimethoxypropene (21.0 mmol) is added via syringe over 1 hour in four equal portions. The suspension is then heated to reflux for an additional 3 hours and cooled to room temperature. The methanol is removed under reduced pressure and the solid is purified by Reversed Phase Chromatography to give 1-[3-S-Acetylthiopropyl]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (29), 1 -[3-S-Acetylthiopropyl]-2-[3-[ 1 -[5-S-acetylthiopropyl]- 1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (30) and 1-ethyl-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (31) as solids. [0048]
    • Example 12 Dye-precursor S-(3-Iodopropyl)isothiourea (32)
  • Thiourea (14 mmol) is added to a solution of 1,3-diiodopropane (340 mmol) in anhydrous methanol (300 mL) and stirred under an atmosphere of nitrogen at 60° C. for 4 hours. The solution is cooled to 4° C. overnight during which time excess 1,3-diiodopropane separates to the bottom of the flask as a colorless oil. The excess 1,3-diiodopropane is removed by pipette and the remaining methanol solution is evaporated in vacuo and the residue is suspended in dichloromethane, filtered, and washed with additional dichloromethane to give S-(3-Iodopropyl)isothiourea (32) as a powder. [0049]
    • Example 13 Dye precursor 1-[3-Isothiouronylpropyl]-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (33)
  • A solution of (32) (0.36 mmol) and 2,3,3-trimethylindoleninium-5-sulfonate, potassium salt (3) (0.46 mmol) are placed in a flask and heated to 148° C. with stirring for 15 minutes under an atmosphere of nitrogen. The reaction mixture is cooled to room temperature and the residue is crystallized from methanol to give 1-[3-isothiouronylpropyl]-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (33) as a powder. [0050]
    • Example 14 Cyanine-3 dyes derived from (33)
  • A solution of (33) (0.022 mmol) and 1-ethyl-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (14) (0.022 mmol) are dissolved in N,N-dimethylformamide containing 50 uL of triethylamine and the mixture is heated to 60° C. as triethylorthoformate (4×10 uL, 4×0.06 mmol) is added in four portions over 3 hours. The solution is heated at 60° C. for an additional hour, cooled to room temperature, washed 3 times with diethyl ether, and the resulting precipitate is purified by reverse phase HPLC to give isolated 1-[3-Isothiouronylpropyl]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene)-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (34), 1-[3-Isothiouronylpropyl]-2-[3-[1 -[3-isothiouronylpropyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (35) and 1-ethyl-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3 -dimethyl-5-sulfo-3H-indolium, potassium salt (17) as solids. [0051]
    • Example 15 Bonding of dye (15) to a target nucleotide derivative
  • To a 2 mL vial with a stir bar is added (15) (1.58 μmol), 5-[3-[3-[2,5-dihydro-2,5-dioxo-1H-pyrrole]propanamido]-1-propynyl]-2′-deoxycytidine triphosphate (36) (5.0 μmol) in 50 mM sodium dihydrogenphosphate pH 7.0 -7.5 (250 μL). To the stirred solution is added 1M hydroxylamine pH 7.0-7.5 (250 μL) and the resulting solution is stirred at room temperature for 1 hour. The reaction mixture is purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium]-2,5-pyrrolidindione]propanamido]-1-propynyl]-2′-deoxycytidine triphosphate (37). [0052]
    • Example 16 Bonding of dye (28) to a target nucleotide derivative
  • The procedure of Example 15 is repeated with (28) substituted for (15). The reaction mixture is purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[3-[1-ethyl-3-methyl-5-sulfo-benz-imidazol-2-ylidene]-1-propenyl]-3,3 dimethyl-5-hydroxyl-6-benz-indolium]-2,5-pyrrolidindione]propanamido]- 1-propynyl]2′-deoxycytidine triphosphate (38). [0053]
    • Example 17 Bonding of dye (29) to a target nucleotide derivative
  • The procedure of Example 15 is repeated with (29) substituted for (15). The reaction mixture is purified to give 5-[3-[3-[3-1-[3-thiopropyl]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]- 1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium]-2,5-pyrrolidindione]propanamido]-1-propynyl]-2′-deoxycytidine triphosphate (39). [0054]
    • Example 18 Dye precursor 1-[3-Isothiouronylpropyl]-2,3,3-trimethyl-3H-indolium iodide (41)
  • To a 50 mL round bottom flask is added 2,3,3-trimethylindolenine (14.4 mmol) and 1,3-diiodopropane (72.7 mmol) and the mixture is stirred at 60° C. under an atmosphere of nitrogen for 16 hours. The resulting solid is recrystallized from ethanol to give 1-[3-iodopropyl]-2,3,3-trimethyl-3H-indolium iodide (40) as crystals. [0055]
  • To a 100 mL round bottom flask is added (40) (4.38 mmol), thiourea (4.5 mmol), and methanol (30 mL). The solution is stirred at 60° C. for 5 hours, evaporated in vacuo, the residue is dissolved in water (20 mL) and washed with dichloromethane (3×6 mL) and cooled to 4° C. overnight, and the resulting crystals are filtered and washed with acetone to give 1-[3-isothiouronylpropyl]-2,3,3-trimethyl-3H-indolium iodide (41). [0056]
    • Example 19 Cyanine-3 dyes derived from (41)
  • To a 25 mL round bottom flask is added (41) (1.0 mmol), (14) (1.5 mmol), and pyridine (10 mL). The solution is heated to reflux and triethyl orthoformate (4×166 uL, 4×1.0 mmol) is added in four portions over one hour. The solution is heated at reflux for an additional hour, cooled to room temperature, the evaporated in vacuo, and the residue is washed with ethyl ether (3×25 mL), and purified by C18 reverse phase chromatography to give isolated 1-[3-isothiouronylpropyl]-2-[3-[1-ethyl- 1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-3H-indolium, inner salt (42), 1-[3-isothiouronylpropyl]-2-[3-[1 -[3-isothiouronylpropyl]-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-3 H-indolium iodide (43) and 1-ethyl-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (17) as solids. [0057]
    • Example 20 Cyanine-5 dyes derived from (41)
  • A solution of (41) (0.28 mmol) and (14) (0.28 mmol) and potassium acetate (0.28 mmol) in methanol (2 mL) is heated to reflux and 1,3,3-trimethoxypropene (160 uL, 1.17 mmol) is added via syringe over 2 hour in four equal portions. A suspension is then heated to reflux for an additional 3 hours and cooled to room temperature. The methanol is removed under reduced pressure and the solid is purified by C18 Reversed Phase Chromatography to give 1-[3-isothiouronylpropyl]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-3H-indolium, inner salt (44), the related di-isothiouronyl-propyl and diethyl inner salts as solids. [0058]
    • Example 21 Bonding of dye (42) to a target nucleotide derivative
  • To a 2 mL vial with a stir bar is added 1-[3-isothiouronylpropyl]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-3H-indolium, inner salt (42) (8 μmol) in 0.1 M potassium hydroxide (1.0 mL). The solution is stirred at room temperature for 1 hour to form the free thiol of (42). Thereafter, (36) (15 μmol) is added to the thiol in aqueous solution. The reaction mixture is purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[3 -[1-ethyl- 1 ,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-3H-indolium]-2,5-pyrrolidindione] propanamido]-1-propynyl]-2′-deoxycytidine triphosphate (45). [0059]
    • Example 22 Bonding of dye (44) to a target nucleotide derivative
  • The procedure of Example 21 is repeated with (44) substituted for (42). The reaction mixture is purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3 -dimethyl-3H-indolium]-2,5-pyrrolidindione]propanamido] -1-propynyl]-2′-deoxycytidine triphosphate (46). [0060]
    • Example 23 Bonding of dye (15) to a target nucleotide derivative
  • To a 5 mL vial with a stir bar is added (15) (19 μmol), 5-[3-[iodoacetamido]-1-propynyl]-2′-deoxycytidine triphosphate (47) (30.0 μmol) in 50 mM sodium dihydrogenphosphate pH 7.0-7.5 (250 μL). To the stirred solution 1M hydroxylamine pH 7.0-7.5 (250 μL) is added. The resulting solution is stirred at room temperature for 4 hours to react the free thiol of (15) with (47). The reaction mixture is purified to give 5-[3-[1-[3-thiopropyl]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium]acetamido-1-propynyl]-2′-deoxycytidine triphosphate (48). [0061]
    • Example 24 Bonding of dye (29) to a target nucleotide derivative
  • The procedure of Example 23 is repeated with (29) substituted for (15). The reaction mixture is purified to give 5-[3-[1-[thiopropyl]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium]acetamido-1-propynyl]-2′-deoxycytidine triphosphate (49). [0062]
    • Example 25 Dye precursor 1-[N-[-3-(tert-butyloxycarbonylamino) propyl]hexanamide]-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (51)
  • To a 100 mL round bottom flask with a stir bar is added 1-[N-[5-carboxypentyl]-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (50) (1.70 mmol) and 40 mL of N,N-dimethylformamide. The mixture is heated at 50° C. until a homogeneous solution is obtained. To this solution is added 1,3-dicyclohexylcarbodiimide (2.30 mmol), N-hydroxysuccinimide (2.34 mmol) and t-butyl N-(3-aminopropyl)carbamate (2.29 mmol). The reaction mixture is heated at 50° C. for 30 min and then room temperature 16 hours. The reaction mixture is filtered, the solvents are removed under reduced pressure and the solid is azeotroped two times with methanol. The solid is purified by Reversed Phase Chromatography to give I-[N-[-3-(tert-butyloxycarbonylamino)propyl] hexanamide]-2,3,3-trimethyl-5-sulfo-3H-indolium, inner salt (51) as a solid. [0063]
    • Example 26 Cyanine-3 dyes derived from (51)
  • A solution of (51) (0.291 mmol) and (14) (0.281 mmol) is heated to reflux in pyridine (30 mL) and triethyl orthoformate (2.4 mmol) is added via syringe over 1 hour in four equal portions. The suspension is then heated to reflux for an additional 4 hours and cooled to room temperature. The solvents are removed under reduced pressure and the solid is azeotroped two times with methanol. The purple solid is purified by Reversed Phase Chromatography and the isolated products are passed over an AG50W-X4, 200-400 mesh K+ form, column to give 1-[N-[3-(tert-butyloxycarbonylamino)-propyl]hexanamide]-2-[3-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]- 1 -propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (52), 1-[N-[3-(tert-butyloxycarbonyl-amino) propyl]hexanamide]-2-[3-[1-[N-[3-(tert-butyloxy-carbonylamino)-propyl]hexanamide]1,3 -dihydro-3 ,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (53) and the related diethyl salt as solids. [0064]
    • Example 27 Cyanine-5 dyes derived from (51)
  • A solution of (51) (0.291 mmol) and (14) (0.292 mmol) and potassium acetate (78 mg, 0.79 mmol) in methanol (15 mL) is heated to reflux and 1,3,3-trimethoxypropene (0.5 mL, 3.64 mmol) is added via syringe over 1 hour in four equal portions. The suspension is then heated to reflux for an additional 3 hours and cooled to room temperature. The methanol is removed under reduced pressure and the solid is purified by Reversed Phase Chromatography to give 1-[N-[3-(tert-butyloxycarbonylamino)propyl]-hexanamide]-2-[5-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1 ,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (54), 1-[N-[3-(tert-butyloxy-carbonyl-amino)propyl]hexanamide]-2-[5-[1-[N-[3-(tert-butyloxycarbonyl-amino)propyl]-hexanamide]-1,3-dihydro-3,3 -dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (55) and the related diethyl salt as solids. [0065]
    • Example 28 Bonding of dye (44) to a target nucleotide derivative
  • To a 2 mL vial with a stir bar is added (44) (17 μmol) and 1 M potassium phosphate (4.0 mL) and methanol (2 mL) and the resulting solution is stirred at room temperature for 1 hour to give 1-[3-thiopropyl]-2-[S-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-3H-indolium, inner salt (56). To this solution is added (36) (34 μmol) and the reaction mixture is stirred for 1 hour and then purified to give 5-[3-[3-[3-[1-[3-thiopropyl]-2-[S-[1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-3H-indolium]-2,5-pyrrolidindione)propanamido]-1-propynyl]-2′-deoxycytidine triphosphate (46). [0066]
    • Example 29 Bonding dye (15) with streptavidin
  • Streptavidin (15 mg) is dissolved in 1 mL 0.1M sodium phosphate buffer, pH 7.0. Sulfosuccinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate (9 mg) in 0.2 mL dimethylsulfoxide is added to the streptavidin solution at room temperature, mixed for 1 hour and purified by gel filtration chromatography to give maleimide derivatized streptavidin. To a 1.5 mL solution of maleimide derivatized streptavidin (3.5 mg) in 0.1M sodium phosphate, 5 mM EDTA buffer, pH 6.0, 1 mg of Cyanine 3 Dye (15) is added followed by 0.15 mL of 1M hydroxylamine pH 7.0. The solution is mixed at room temperature for 1 hour and then 20 μL of 0.1M N-ethylmaleimide is added and the mixture is stored at 4° C. for 16 hours. The mixture is purified by gel filtration chromatography to give streptavidin modified with Cyanine 3 Dye (15). [0067]
    • Example 30 Bonding dye 16 with streptavidin
  • Streptavidin (15 mg) is dissolved in 1 mL 0.1M sodium phosphate buffer, pH 7.0. Sulfosuccinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate (9 mg) in 0.2 mL dimethylsulfoxide is added to the streptavidin solution at room temperature, mixed for 1 hour and purified by gel filtration chromatography to give maleimide derivatized streptavidin. To a 1.5 mL solution of maleimide derivatized streptavidin (3.5 mg) in 0.1M sodium phosphate, 5 mM EDTA buffer, pH 6.0, 1 mg of Cyanine 3 Dye (16) is added followed by 0.15 mL of 1M hydroxylamine pH 7.0. The solution is mixed at room temperature for 1 hour and then 20 μL of 0.1M N-ethylmaleimide is added and the mixture is stored at 4° C. for 16 hours. The mixture is purified by gel filtration chromatography to give streptavidin modified with Cyanine 3 Dye (16). [0068]
    • Example 31 Bonding of dye (15) with neurotensin on resin
  • Fmoc-Neurotensin on Resin (Wang polymer) 100 mg (substitution 0.6 mmol/g) is swelled in dimethy fornamide (DMF) for 30 minutes where Fmoc has the structure: [0069]
    Figure US20010020098A1-20010906-C00008
  • Fmoc is removed by reaction with 25% Piperidine/DMF (about 20 ml×3 min, wash with DMF, and 20 ml×20 min). Resin is washed with DMF 7×20 ml (1 min each washing step). 25 mg of (N-[gamma-malemidobutryloxy] succinimide ester (Sulfo-GMBS) in DMF (15 ml) is added and mixed with resin 24 hours. After reaction the resin is washed 7×20 ml of DMF. Cyanine (15) (10 mg) solution in DMF/methanol (15 ml) is added along with 5 ml 1 M solution of hydroxylamine in water. Reaction is performed overnight. After washing with DMF (7×20 ml) and methanol (3×30 ml) resin is dried. Labeled peptide is cleaved from resin with Reagent K (92.5% TFA!2.5% EDT/2.5% water/2.5% TIS) 10 ml for 2 hours. Crude peptide is precipitated with cold diethyl ether and centrifuged. Precipitate is dissolved in 50% Acetonitrile/water and lyophilized. [0070]
    • Example 32 Bonding of dye (15) with galanin on resin
  • Fmoc-Galinin on Resin is swelled as in Example 31. Orthogonal protection on Lys 25 ((4,4-dimethyl-2,6 dioxocyclohex-1-ylidene)ethyl-Dde) is removed by reaction with 2% hydrazine hydrate (2×20 ml, 2 min). Resin is washed 6 times with DMF (20 ml). 25 mg of Sulfo-GMBS in DMF (15 ml) is added and mixed with resin for 24 hours. After reaction the resin was washed 7×20 ml of DMF, (15) (10 mg) solution in DMF/MeOH (15 ml) is added along with 5 ml 1 M solution of hydroxylamine in water. Reaction is performed overnight. Labeled galanin is purified and isolated as per Example 32. [0071]
    • Example 33 Bonding of dye (29) with a native peptide-bradykinin
  • Bradykinin (3 mg) dissolved in 1 ml of 50 mM sodium dihydrogen phosphate pH 7.5, and added sulfoGMBS (3.4 mg), mixed for 2 hours in room temperature. To the reaction mixture is added 1 ml of solution (5.8 mg) of (29) in sodium dihydrogen phosphate pH 7.5 and 0.5 ml 1M hydroxylamine (pH 7), and mixed overnight. Labeled peptide is lyophilized. [0072]
    • Example 34 Bonding of dye (29) with liposomes
  • The procedure of Example 33 is repeated with the substitution of liposomes as per Example 1 of U.S. Pat. No. 4,089,801 for bradykinin. The liposome including lecithin and amyloglucoside therein. A labeled liposome is purified therefrom. [0073]
    • Example 35 Bonding of 1-13-N-acetylaminopropyl]-2-15-1-[ethyl-1,3 dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-3,3-dimethyl-5-sulfo-3H-indolium, potassium salt (58) to a target nucleotide derivative
  • The dye (58) is prepared as per Examples 1 and 11 using the amine analog to the dye precursor (5). The dye (58) is combined with (36) as per Example 28 to yield the amine analog to (46). [0074]
  • Those skilled in the art will appreciate from the foregoing description and examples that the broad teaching of the present invention can be implemented in a variety of forms. Therefore, while this invention has been described in connection with particular examples thereof, the true scope of the invention should not be so limited since other modifications will become apparent to one skilled in the art upon review of the specification and the following claims. [0075]
  • All patents and other publications cited herein are expressly incorporated by reference to the same extent as if each individual publication were specifically and individually indicated to be incorporated by reference. [0076]
    TABLE I
    Cyanine-3 dyes derived from precursors (7), (10), (13) and the 1-ethyl analogs thereof in terms of dye formula (2)
    Com-
    Ex- pound
    ample # R1 R2 R3 R4 R5 R6 R7 R8 Y1 Y2 R11 R12
    6 (18) H OH —C4H4— H OH —C4H4— —C(C2H5)2— —C(C2H5)2— C3H6SC(O)CH3 C2H5
    (7) + (19) H OH —C4H4— H OH —C4H4— —C(C2H5)2— —C(C2H5)2— C3H6SC(O)CH3 C3H6SC(O)C
    1-Et(7) (20) H OH —C4H4— H OH —C4H4— —C(C2H5)2— —C(C2H5)2— C2H5 C2H5
    7 (21) COO− H H H COO− H H H —O— —O— C4H8SC(O)C6H5 C2H5
    10 + (22) COO− H H H COO− H H H —O— —O— C4H8SC(O)C6H5 C4H8SC(O)C
    1-Et(10) (23) COO− H H H COO− H H H —O— —O— C2H5 C2H5
    8 (24) H SO3 − H H H SO3 − H H —N(CH3)— —N(CH3)— C4H8SC(CH3)3 C2H5
    13 + (25) H SO3 − H H H SO3 − H H —N(CH3)— —N(CH3)— C4H8SC(CH3)3 C4H8SC(CH3)
    1-Et(10) (26) H SO3 − H H H SO3 − H H —N(CH3)— —N(CH3)— C2H5 C2H5
    9 (19) H OH —C4 H4— COO− H H H —C(C2H5)2— —O— C3H6SC(O)CH3 C2H5
    7 + (23)
    1-Et(10) (27)
    10 (19) H OH —C4 H4— H SO3 − H H —C(C2H5)2— —N(CH3)— C3H6SC(O)CH3 C2H5
    (7) + (26)
    1-Et(13) (28)

Claims (16)

1. A dye compound comprising the formula:
Figure US20010020098A1-20010906-C00009
wherein R1, R2, R3, R4, R5, R6, R7, and R8 are each independently selected from a group consisting of hydrogen, C1-C6 alkyl group, a C0-C4 alkyl group having a hydrophilic substituent selected from a group consisting of sulfonate, carboxylate, hydroxyl, substituted amines and quaternary amines;
wherein Y1 and Y2 are each independently selected from a group consisting of:
Figure US20010020098A1-20010906-C00010
wherein R9, R′9, R10, and R′10 are each independently selected from a group consisting of C1-C6 alkyl, and a heteroatom substituted C1-C6 alkyl wherein the heteroatom is O, N or S;
wherein R11 and R12 are each independently selected from a group consisting of C1-C30 alkyl, phenyl substituted C1-C30, C1-C30 having a protected substituent selected from a group consisting of:
Figure US20010020098A1-20010906-C00011
wherein R13, R′13, R″13 and R′″13 are each independently C1-C30 alkyl, Q is sulfur, nitrogen or oxygen, X is a halogen and Y is a halogen and at least one of R11 and R12 is the C1-C30 having the protected substituent; and
L is selected from a group consisting of: methine, a methine group having a substituent C1-C30 alkyl group and a substituted C1-C30 alkyl group having a phenyl, hydroxyl, sulfonyl, a halogen atom, a heteroatom substituted phenyl and a C1-C4 alkoxyl where n is 1, 2, 3 or greater.
2. The dye compound of
claim 1
 wherein at least one of R1-R12, R9′ and R10′ is the C0-C4 alkyl group having the hydrophilic substituent.
3. The dye compound of
claim 1
 wherein at least two adjacent R groups of R1-R8, R9, R9′, R10 and R10′ are fused to form a ring structure.
4. The dye compound of
claim 1
 wherein both R11 and R12 are the C1-C30 having the protected substituent.
5. The dye compound of
claim 1
 wherein only one of R11 and R12 are the C1-C30 having the protected substituent.
6. The dye compound of
claim 1
 wherein the protected substituent reacts with a deprotecting agent to form a reactive group selected from a group consisting of: thiol, amine and hydroxyl.
7. A dye compound comprising the formula:
Figure US20010020098A1-20010906-C00012
wherein R1, R2, R3, R4, R5, R6, R7, and R8 are each independently selected from a group consisting of hydrogen, C1-C6 alkyl group, a C0-C4 alkyl group having a hydrophilic substituent selected from a group consisting of sulfonate, carboxylate, hydroxyl, substituted amines and quaternary amines, such that at least one of R1-R12, R9′ and R10′ is the C0-C4 alkyl group having the hydrophilic substituent;
wherein Y1 and Y2 are each independently selected from a group consisting of:
Figure US20010020098A1-20010906-C00013
wherein R9, R′9, R10, and R′10 are each independently selected from a group consisting of C1-C6 alkyl, and a heteroatom substituted C1-C6 alkyl wherein the heteroatom is O, N or S;
wherein R11 and R12 are each independently selected from a group consisting of R14H, R14SH, R14NH2 and R14OH;
wherein R14 is selected from a group consisting of: C3-C30 alkyl and C3-C30 alkyl having a phenyl, hydroxyl, sulfonyl, or halogen atom or a heteroatom substituted phenyl; and
L is selected from a group consisting of: methine, a methine group having a substituent C1-C30 alkyl group and a substituted C1-C30 alkyl group having a phenyl, hydroxyl, sulfonyl, a halogen atom, a heteroatom substituted phenyl and a C1-C4 alkoxyl where n is 1, 2, 3 or greater.
8. The dye compound of
claim 7
 wherein at least two adjacent R groups of R1-R8, R9, R9′, R10 and R10′ are fused to form a ring structure.
9. The dye compound of
claim 7
 wherein R11 and R12 are both the nucleophilic substituents.
10. The dye compound of
claim 7
 wherein only one of R11 and R12 is the nucleophilic substituent.
11. A process for preparing a compound (2) as claimed in
claim 1
 which comprises reacting a compound (1) with a molecule selected from the group consisting of: trialkyl orthoformate, dialkyl amide, trialkoxy alkene and C3-C12 bisaldehyde wherein the alkyl and alkoxy groups are independently C1-C6 and the alkene is C3 or C5 in the presence of a base and the C3-C12 bisaldehyde in the presence of an alcohol.
12. A process for preparing a compound (2) as claimed in
claim 7
 which comprises reacting a compound (1) with a molecule selected from the group consisting of: trialkyl orthoformate, dialkyl amide, trialkoxy alkene and C3-C12 bisaldehyde wherein the alkyl and alkoxy groups are independently C1-C6 and the alkene is C3 or C5 in the presence of a base and the C3-C12 bisaldehyde in the presence of an alcohol.
13. The process of
claim 11
 wherein the base is selected from a group consisting of: pyridine, C1-C4 alkoxide and C1-C4 morpholine, piperidine, t-butyl amine, triethylamine, and an amine.
14. The dye compound of
claim 5
 wherein the C1-C30 having the protected substituent is a sulfur containing moiety.
15. The dye compound of
claim 5
 wherein the R11 or R12 group lacking the protected C1-C30 protected substituent is the C1-C30 alkyl.
16. The dye compound of
claim 5
 wherein one of R11 or R12 is R14SH and the other of R11 or R12 is R14H.
US09/824,316 1999-04-19 2001-04-02 Cyanine dyes and synthesis methods thereof Expired - Lifetime US6437141B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/824,316 US6437141B2 (en) 1999-04-19 2001-04-02 Cyanine dyes and synthesis methods thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/294,678 US6114350A (en) 1999-04-19 1999-04-19 Cyanine dyes and synthesis methods thereof
US09/448,242 US6224644B1 (en) 1999-04-19 1999-11-24 Cyanine dyes and synthesis methods thereof
US09/824,316 US6437141B2 (en) 1999-04-19 2001-04-02 Cyanine dyes and synthesis methods thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/448,242 Continuation US6224644B1 (en) 1999-04-19 1999-11-24 Cyanine dyes and synthesis methods thereof

Publications (2)

Publication Number Publication Date
US20010020098A1 true US20010020098A1 (en) 2001-09-06
US6437141B2 US6437141B2 (en) 2002-08-20

Family

ID=23134462

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/294,678 Expired - Lifetime US6114350A (en) 1999-04-19 1999-04-19 Cyanine dyes and synthesis methods thereof
US09/449,333 Expired - Lifetime US6197956B1 (en) 1999-04-19 1999-11-24 Cyanine dyes and synthesis methods thereof
US09/448,241 Expired - Lifetime US6204389B1 (en) 1999-04-19 1999-11-24 Cyanine dyes and synthesis methods thereof
US09/448,242 Expired - Lifetime US6224644B1 (en) 1999-04-19 1999-11-24 Cyanine dyes and synthesis methods thereof
US09/824,316 Expired - Lifetime US6437141B2 (en) 1999-04-19 2001-04-02 Cyanine dyes and synthesis methods thereof

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US09/294,678 Expired - Lifetime US6114350A (en) 1999-04-19 1999-04-19 Cyanine dyes and synthesis methods thereof
US09/449,333 Expired - Lifetime US6197956B1 (en) 1999-04-19 1999-11-24 Cyanine dyes and synthesis methods thereof
US09/448,241 Expired - Lifetime US6204389B1 (en) 1999-04-19 1999-11-24 Cyanine dyes and synthesis methods thereof
US09/448,242 Expired - Lifetime US6224644B1 (en) 1999-04-19 1999-11-24 Cyanine dyes and synthesis methods thereof

Country Status (6)

Country Link
US (5) US6114350A (en)
EP (1) EP1112254B1 (en)
JP (1) JP2002542365A (en)
AU (1) AU767368B2 (en)
CA (1) CA2335240C (en)
WO (1) WO2000063296A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109206351A (en) * 2018-09-18 2019-01-15 许昌学院 A kind of near infrared fluorescent probe, preparation method and application for surveying palladium ion based on flower cyanines structure
CN109467523A (en) * 2018-12-17 2019-03-15 苏州华道生物药业股份有限公司 A kind of green synthesis method of the third sulfonic acid chloride of 3- chlorine
WO2020186483A1 (en) * 2019-03-20 2020-09-24 深圳大学 Pentamethine cyanine dye and preparation method therefor

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593148B1 (en) 1994-03-01 2003-07-15 Li-Cor, Inc. Cyanine dye compounds and labeling methods
US20080050836A1 (en) * 1998-05-01 2008-02-28 Isabelle Guyon Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia
JP2000095758A (en) 1998-09-18 2000-04-04 Schering Ag Near-infrared, fluorescent contrast medium, and its production
US7547721B1 (en) 1998-09-18 2009-06-16 Bayer Schering Pharma Ag Near infrared fluorescent contrast agent and fluorescence imaging
US6114350A (en) * 1999-04-19 2000-09-05 Nen Life Science Products, Inc. Cyanine dyes and synthesis methods thereof
US20040044219A1 (en) * 2000-06-07 2004-03-04 Jennie Sandstrom Probe for analysis of nucleic acids
DE10046215B4 (en) * 2000-09-19 2004-04-15 Institut für Chemo- und Biosensorik Münster e.V. i.Ins. Fluorochromes and their use
ATE352586T2 (en) * 2000-09-29 2007-02-15 Molecular Probes Inc MODIFIED CARBOCYANINE DYES AND CONJUGATES THEREOF
US6663847B1 (en) * 2000-10-13 2003-12-16 Mallinckrodt Inc. Dynamic organ function monitoring agents
US6379622B1 (en) 2001-04-11 2002-04-30 Motorola, Inc. Sensor incorporating a quantum dot as a reference
US6694158B2 (en) 2001-04-11 2004-02-17 Motorola, Inc. System using a portable detection device for detection of an analyte through body tissue
US7521019B2 (en) * 2001-04-11 2009-04-21 Lifescan, Inc. Sensor device and methods for manufacture
US6454710B1 (en) 2001-04-11 2002-09-24 Motorola, Inc. Devices and methods for monitoring an analyte
US6887690B2 (en) * 2001-06-22 2005-05-03 Pe Corporation Dye-labeled ribonucleotide triphosphates
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US20050123913A1 (en) * 2001-08-30 2005-06-09 Emory University Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays
US7166478B2 (en) * 2002-03-12 2007-01-23 Enzo Life Sciences, Inc., C/O Enzo Biochem, Inc. Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
AU2003232089A1 (en) * 2002-05-06 2003-11-17 Perkinelmer Life Sciences, Inc. Separation process and dyes for use therewith
AU2003280470A1 (en) * 2002-07-01 2004-01-19 Guava Technologies, Inc. Fluorescent dyes, energy transfer couples and methods
CN1307263C (en) * 2002-07-08 2007-03-28 通用电气医疗集团英国有限公司 Reagent and method for saturation labelling of proteins
CA2501144C (en) * 2002-10-23 2015-10-06 University Of Utah Research Foundation Amplicon melting analysis with saturation dyes
US20040132092A1 (en) * 2003-01-03 2004-07-08 Stetson Christopher M. Determining the density of functional moieties on polymer reagents
AU2003234038B2 (en) * 2003-05-28 2008-02-21 Ge Healthcare Uk Limited Differential analysis of cell surface proteins on closed membrane structures by labelling with dyes in the presence of an internal standard
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7271265B2 (en) * 2003-08-11 2007-09-18 Invitrogen Corporation Cyanine compounds and their application as quenching compounds
CA2538797A1 (en) * 2003-09-12 2005-03-24 Invitrogen Corporation Multiplex binding and activity assays
US7776529B2 (en) 2003-12-05 2010-08-17 Life Technologies Corporation Methine-substituted cyanine dye compounds
EP1720944B1 (en) * 2003-12-05 2013-07-17 Life Technologies Corporation Cyanine dye compounds
JP4127204B2 (en) * 2003-12-17 2008-07-30 セイコーエプソン株式会社 Manufacturing method of liquid crystal display device
US7705150B2 (en) * 2004-02-04 2010-04-27 Biosearch Technologies, Inc. Cyanine dyes
US9657347B2 (en) 2004-04-20 2017-05-23 University of Utah Research Foundation and BioFire Defense, LLC Nucleic acid melting analysis with saturation dyes
US7387887B2 (en) * 2004-04-20 2008-06-17 University Of Utah Research Foundation Nucleic acid melting analysis with saturation dyes
US7456281B2 (en) * 2005-04-20 2008-11-25 Idaho Technology, Inc. Nucleic acid melting analysis with saturation dyes
US7598390B2 (en) * 2005-05-11 2009-10-06 Life Technologies Corporation Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
US7737281B2 (en) * 2005-05-24 2010-06-15 Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc. Purine based fluorescent dyes
US7569695B2 (en) * 2005-05-24 2009-08-04 Enzo Life Sciences, Inc. Dyes for the detection or quantification of desirable target molecules
US8357801B2 (en) 2005-05-24 2013-01-22 Enzo Life Sciences, Inc. Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits
FR2889700B1 (en) 2005-08-11 2012-11-23 Synthinnove Lab MARKERS, METHOD FOR PRODUCING THE SAME, AND APPLICATIONS THEREOF
JP2008133458A (en) * 2006-10-27 2008-06-12 Fujifilm Corp Radioisotope-labeled pigment compound
FR2921258A1 (en) * 2007-09-24 2009-03-27 Oreal TINCTORIAL COMPOSITION COMPRISING AT LEAST ONE COLOR DISULFIDE / THIOL PRECURSOR, COLORING PROCESS FROM THE COMPOSITION
US20100291706A1 (en) * 2009-05-15 2010-11-18 Millipore Corporation Dye conjugates and methods of use
US8536323B2 (en) 2010-04-21 2013-09-17 Pierce Biotechnology, Inc. Modified nucleotides
US9206216B2 (en) 2010-04-21 2015-12-08 Pierce Biotechnology, Inc. Modified nucleotides methods and kits
WO2012027623A2 (en) 2010-08-25 2012-03-01 Pacific Biosciences Of California, Inc. Cyanine dyes
US20120088262A1 (en) * 2010-10-06 2012-04-12 Millipore Corporation Cyanine compounds, conjugates and method of use
WO2012103678A1 (en) * 2011-01-31 2012-08-09 大连理工大学 Pentamethine cyanine fluorescent dyes, preparation methods and uses thereof
US9416153B2 (en) 2011-10-11 2016-08-16 Enzo Life Sciences, Inc. Fluorescent dyes
US9315864B2 (en) 2012-05-18 2016-04-19 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes with sulfonic acid substituents
WO2013173844A1 (en) 2012-05-18 2013-11-21 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes
US10300153B2 (en) 2015-11-30 2019-05-28 Asthra, Llc Immunological detection of altered cells
US10947253B2 (en) 2019-08-05 2021-03-16 Ankh Life Sciences Limited Fused polycyclic dimers
KR102550713B1 (en) * 2021-01-18 2023-07-03 (주)바이오액츠 Fluorescent compound with cyanuric-hydroxide and the preparation method thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138551A (en) * 1975-03-18 1979-02-06 Ciba-Geigy Ag Spectral sensitization of photographic material and new spectral sensitizers
JPS53144727A (en) * 1977-05-24 1978-12-16 Konishiroku Photo Ind Co Ltd Photographic product
JPS62123454A (en) * 1985-08-08 1987-06-04 Fuji Photo Film Co Ltd Silver halide photographic sensitive material
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US5627027A (en) * 1986-04-18 1997-05-06 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US5149610A (en) * 1987-01-19 1992-09-22 Canon Kabushiki Kaisha Color toner and two-component developer containing same
US4859572A (en) * 1988-05-02 1989-08-22 Eastman Kodak Company Dye sensitized photographic imaging system
US4981977A (en) * 1989-06-09 1991-01-01 Carnegie-Mellon University Intermediate for and fluorescent cyanine dyes containing carboxylic acid groups
US5378634A (en) * 1992-08-20 1995-01-03 Matsushita Electric Industrial Co., Ltd. Labelling color for detecting methamphetamine
US5401100A (en) * 1992-12-18 1995-03-28 Pymah Corporation Axillary thermometer packaging
US5658751A (en) * 1993-04-13 1997-08-19 Molecular Probes, Inc. Substituted unsymmetrical cyanine dyes with selected permeability
US5744511A (en) * 1995-04-19 1998-04-28 Tokuyama Corporation Visible ray polymerization initiator and visible ray polymerizable composition
US5652258A (en) * 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives
US5786123A (en) * 1996-03-19 1998-07-28 Eastman Kodak Company Optical recording elements comprising a polymeric dye
GB9604996D0 (en) * 1996-03-08 1996-05-08 Black James Foundation Benzodiazonine derivatives
US5863727A (en) * 1996-05-03 1999-01-26 The Perkin-Elmer Corporation Energy transfer dyes with enhanced fluorescence
JP3396131B2 (en) * 1996-06-28 2003-04-14 三菱電機株式会社 Semiconductor device and manufacturing method thereof
US5688966A (en) * 1996-07-26 1997-11-18 E. I. Du Pont De Nemours And Company Compounds and method for synthesizing sulfoindocyanine dyes
JP3579195B2 (en) * 1996-08-30 2004-10-20 富士写真フイルム株式会社 Silver halide photographic material
US6027709A (en) * 1997-01-10 2000-02-22 Li-Cor Inc. Fluorescent cyanine dyes
DE19717904A1 (en) * 1997-04-23 1998-10-29 Diagnostikforschung Inst Acid-labile and enzymatically cleavable dye constructs for diagnostics with near infrared light and for therapy
US5986086A (en) * 1997-06-20 1999-11-16 Amersham Pharmacia Biotech Inc. Non-sulfonated cyanine dyes for labeling nucleosides and nucleotides
US6114350A (en) * 1999-04-19 2000-09-05 Nen Life Science Products, Inc. Cyanine dyes and synthesis methods thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109206351A (en) * 2018-09-18 2019-01-15 许昌学院 A kind of near infrared fluorescent probe, preparation method and application for surveying palladium ion based on flower cyanines structure
CN109467523A (en) * 2018-12-17 2019-03-15 苏州华道生物药业股份有限公司 A kind of green synthesis method of the third sulfonic acid chloride of 3- chlorine
WO2020186483A1 (en) * 2019-03-20 2020-09-24 深圳大学 Pentamethine cyanine dye and preparation method therefor

Also Published As

Publication number Publication date
EP1112254A2 (en) 2001-07-04
WO2000063296A2 (en) 2000-10-26
US6204389B1 (en) 2001-03-20
EP1112254B1 (en) 2013-02-27
CA2335240A1 (en) 2000-10-26
US6114350A (en) 2000-09-05
AU767368B2 (en) 2003-11-06
EP1112254A4 (en) 2005-03-16
JP2002542365A (en) 2002-12-10
US6197956B1 (en) 2001-03-06
US6224644B1 (en) 2001-05-01
WO2000063296A3 (en) 2001-02-15
US6437141B2 (en) 2002-08-20
CA2335240C (en) 2013-11-26
AU4363100A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
US6437141B2 (en) Cyanine dyes and synthesis methods thereof
US6995274B2 (en) Cyanine dyes
US8148539B2 (en) Cyanine dye labelling reagents
US9624424B2 (en) Large stokes shift dyes
US20100143960A1 (en) Cyanine derivatives, fluorescent conjugates containing same and use thereof
US20040260072A1 (en) Hydrophilic, thiol-reactive cyanine dyes and conjugates thereof with biomolecules for fluorescence diagnosis
WO2001021624A1 (en) Compounds for fluorescence labeling
US20120004391A2 (en) Cyanine-type compounds having an alkynyl linker arm
US8034626B2 (en) Labels, their production process and their uses
US6403625B1 (en) Fluorescent labeling reagents
EP1163372A1 (en) Chemically reactive plane-rigidized cyanine dyes and their derivatives
US20040023408A1 (en) Site-specific labelling of proteins using cyanine dye reporters

Legal Events

Date Code Title Description
AS Assignment

Owner name: NEN LIFE SCIENCE PRODUCTS, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RANDALL, MALCOLM HARRY;BUZBY, PHILIP RICHARD;ERICKSON, THOMAS JOSEPH;AND OTHERS;REEL/FRAME:013030/0036;SIGNING DATES FROM 19990416 TO 19990428

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 4

SULP Surcharge for late payment
FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12